Chison Medical Technologies Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Chison Medical Technologies Co., Ltd. carries a market capitalization of 3.73B, placing it among publicly traded companies globally. Its enterprise value stands at 2.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.73B |
| Enterprise Value | 2.19B |
Share Statistics
Chison Medical Technologies Co., Ltd. currently has 112.12M shares outstanding.
| Shares Outstanding | 112.12M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Chison Medical Technologies Co., Ltd. trades at a trailing price-to-earnings ratio of 25.88. The price-to-sales ratio is 7.29, and the price-to-book ratio stands at 7.81.
| PE Ratio | 25.88 |
| PS Ratio | 7.29 |
| PB Ratio | 7.81 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 225.80 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Chison Medical Technologies Co., Ltd. trades at an EV/EBITDA multiple of 20.32 and an EV/FCF ratio of 146.12. The EV/Sales ratio of 4.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.32 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.79 |
| EV / EBITDA | 20.32 |
| EV / EBIT | 20.32 |
| EV / FCF | 146.12 |
Financial Position
Chison Medical Technologies Co., Ltd. maintains a current ratio of 5.42, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.38, indicating conservative leverage, while an interest coverage ratio of 411.60 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.42 |
| Quick Ratio | 4.25 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.05 |
| Interest Coverage | 411.60 |
Financial Efficiency
Chison Medical Technologies Co., Ltd. posts a return on equity of 30.79 and a return on invested capital of 7.01.
| Return on Equity (ROE) | 30.79 |
| Return on Assets (ROA) | 7.92 |
| Return on Invested Capital (ROIC) | 7.01 |
| Return on Capital Employed (ROCE) | 30.36 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.59 |
Taxes
Over the trailing twelve months, Chison Medical Technologies Co., Ltd. has paid 15.62M in income taxes, reflecting an effective tax rate of 10.81.
| Income Tax | 15.62M |
| Effective Tax Rate | 10.81 |
Stock Price Statistics
Chison Medical Technologies Co., Ltd.'s stock has gained approximately 11.09626% over the past 52 weeks. The 50-day moving average sits at 32.66, while the 200-day moving average is 32.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | 11.09626% |
| 50-Day Moving Average | 32.66 |
| 200-Day Moving Average | 32.70 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Chison Medical Technologies Co., Ltd. generated 457.28M in revenue and converted that into 128.86M in net income, yielding earnings per share of 1.15. EBITDA reached 107.87M, while operating income came in at 107.87M.
| Revenue | 457.28M |
| Gross Profit | 270.78M |
| Operating Income | 107.87M |
| Pretax Income | 144.47M |
| Net Income | 128.86M |
| EBITDA | 107.87M |
| EBIT | 107.87M |
| Earnings Per Share (EPS) | 1.15 |
Balance Sheet
Chison Medical Technologies Co., Ltd. holds 1.15B in cash and equivalents against 5.28M in total debt, resulting in a net debt position of -1.05B. Total book value stands at 426.93M, with working capital of 1.19B providing operational flexibility.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 5.28M |
| Net Debt | -1.05B |
| Equity (Book Value) | 426.93M |
| Book Value Per Share | 3.80 |
| Working Capital | 1.19B |
Cash Flow
After subtracting -14.77M in capital expenditures, free cash flow totaled -14.77M - equivalent to -0.13 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -14.77M |
| Free Cash Flow | -14.77M |
| FCF Per Share | -0.13 |
Margins
Chison Medical Technologies Co., Ltd. operates with a gross margin of 59.21, reflecting its pricing power and cost economics. The operating margin of 23.59 and net profit margin of 28.18 provide insight into operational efficiency.
| Gross Margin | 59.21 |
| Operating Margin | 23.59 |
| Pretax Margin | 31.59 |
| Profit Margin | 28.18 |
| EBITDA Margin | 23.59 |
Dividends & Yields
The company's payout ratio of 44.59 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.51 |
| Dividend Yield | N/A |
| Payout Ratio | 44.59 |
| Shareholder Yield | 2.81 |
| FCF Yield | 0.44 |
Stock Splits
Chison Medical Technologies Co., Ltd.'s most recent stock split took place on July 7, 2022 with a 5:7 split ratio.
| Last Split Date | 7/7/2022 |
| Split Ratio | 5:7 |
Scores
Chison Medical Technologies Co., Ltd. posts an Altman Z-Score of 8.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.78 |